170 related articles for article (PubMed ID: 32996252)
1. SLC38A2 Overexpression Induces a Cancer-like Metabolic Profile and Cooperates with SLC1A5 in Pan-cancer Prognosis.
Huang MS; Chang JH; Lin WC; Cheng YH; Li FA; Suen CS; Hwang MJ; Chang CK; Mou KY
Chem Asian J; 2020 Nov; 15(22):3861-3872. PubMed ID: 32996252
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
Jeon YJ; Khelifa S; Ratnikov B; Scott DA; Feng Y; Parisi F; Ruller C; Lau E; Kim H; Brill LM; Jiang T; Rimm DL; Cardiff RD; Mills GB; Smith JW; Osterman AL; Kluger Y; Ronai ZA
Cancer Cell; 2015 Mar; 27(3):354-69. PubMed ID: 25759021
[TBL] [Abstract][Full Text] [Related]
3. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells.
Bröer A; Rahimi F; Bröer S
J Biol Chem; 2016 Jun; 291(25):13194-205. PubMed ID: 27129276
[TBL] [Abstract][Full Text] [Related]
5. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
[TBL] [Abstract][Full Text] [Related]
6. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
[TBL] [Abstract][Full Text] [Related]
7. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
[TBL] [Abstract][Full Text] [Related]
8. CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin.
Hua Q; Zhang B; Xu G; Wang L; Wang H; Lin Z; Yu D; Ren J; Zhang D; Zhao L; Zhang T
Oncogene; 2021 Nov; 40(46):6443-6455. PubMed ID: 34608265
[TBL] [Abstract][Full Text] [Related]
9. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
Zhao X; Petrashen AP; Sanders JA; Peterson AL; Sedivy JM
Aging Cell; 2019 Jun; 18(3):e12947. PubMed ID: 30909319
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.
Zhou X; Zheng W; Nagana Gowda GA; Raftery D; Donkin SS; Bequette B; Teegarden D
J Steroid Biochem Mol Biol; 2016 Oct; 163():147-56. PubMed ID: 27154413
[TBL] [Abstract][Full Text] [Related]
11. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1.
Kandasamy P; Zlobec I; Nydegger DT; Pujol-Giménez J; Bhardwaj R; Shirasawa S; Tsunoda T; Hediger MA
Mol Oncol; 2021 Oct; 15(10):2782-2800. PubMed ID: 34003553
[TBL] [Abstract][Full Text] [Related]
13. Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.
Toda K; Nishikawa G; Iwamoto M; Itatani Y; Takahashi R; Sakai Y; Kawada K
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749408
[TBL] [Abstract][Full Text] [Related]
14. Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells.
Li S; Zhou Q; Liu W; Fu Z; Zhao H; Xi S
Toxicol Lett; 2021 Jul; 345():1-11. PubMed ID: 33781819
[TBL] [Abstract][Full Text] [Related]
15. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
[TBL] [Abstract][Full Text] [Related]
16. TFEB controls retromer expression in response to nutrient availability.
Curnock R; Calcagni A; Ballabio A; Cullen PJ
J Cell Biol; 2019 Dec; 218(12):3954-3966. PubMed ID: 31694921
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.
Zhang H; Cui K; Yao S; Yin Y; Liu D; Huang Z
Pathol Res Pract; 2021 Aug; 224():153525. PubMed ID: 34171602
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer.
Morotti M; Zois CE; El-Ansari R; Craze ML; Rakha EA; Fan SJ; Valli A; Haider S; Goberdhan DCI; Green AR; Harris AL
Br J Cancer; 2021 Jan; 124(2):494-505. PubMed ID: 33028955
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the galectin-12 protein interactome reveals a major impact of galectin-12 on glutamine anaplerosis in colon cancer cells.
Katzenmaier EM; Fuchs V; Warnken U; Schnölzer M; Gebert J; Kopitz J
Exp Cell Res; 2019 Jun; 379(2):129-139. PubMed ID: 30935948
[TBL] [Abstract][Full Text] [Related]
20. Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade.
Choudhury M; Schaefbauer KJ; Kottom TJ; Yi ES; Tschumperlin DJ; Limper AH
Am J Respir Cell Mol Biol; 2023 Oct; 69(4):441-455. PubMed ID: 37459644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
